Clarity is thrilled to announce positive results from its Feasibility, Safety and Tolerability study for a novel non-invasive neuromodulation treatment. Clarity's groundbreaking approach is the first to deliver 40Hz gamma-frequency light and sound stimulation via virtual reality (VR) technology to address key pathophysiological markers of Alzheimer’s disease (AD), including neuroinflammation and synaptic dysfunction.